NATIONAL
CALIFORNIA
VENTURA
policies
- VC 705.07 Cardiac Arrest – Asystole/Pulseless Electrical Activity (PEA)
- VC 705.08 Cardiac Arrest – VF/VT
- VC 705.11 Crush Injury/Syndrome
- VC 705.18 Overdose
- VC 705.24 Symptomatic Bradycardia
- SB 533-09b Cardiac Arrest – VF/VT
- SB 533-09c Cardiac Arrest – Asystole/Pulseless Electrical Activity (PEA)
- SB 533-12 Symptomatic Bradycardia
- SB 533-16 Poisoning/Overdose
- SB 533-25 Potential Crush Injury/Crush Syndrome
- LA County Ref. No. 1210 Cardiac Arrest
- LA County Ref. No. 1212 Cardiac Dysrhythmia – Bradycardia
- LA County Ref. No. 1241 Overdose / Poisoning / Ingestion
- LA County Ref. No. 1242 Crush Injury / Syndrome
category
mechanism
- In water, sodium bicarbonate dissociates into a sodium ion (Na+) and bicarbonate ion (HCO3-). Carbonic anhydrase combines HCO3- with a hydrogen ion (H+) forming carbonic acid (H2CO3) which then breaks down into water (H2O) and carbon dioxide (CO2).
indications
- Metabolic acidosis: Management of metabolic acidosis caused by certain poisonings including ethylene glycol (antifreeze, aspirin and methanol).
- Urine alkalinization: Alkalinization of the urine promotes excretion of some drugs including aspirin and barbiturates.
- Hyperkalemia: Sodium bicarbonate lowers of serum potassium by alkalinizing the blood and causing the potassium to shift into the cells (and hydrogen ions to shift out). In crush injuries, potassium is released from ruptured cells causing hyperkalemia.
contraindications
- Alkalosis: Often due to vomiting or use of diuretics
- Edema, kidney impairment and/or heart failure: Can worsen sodium and fluid retention
dosing
Adult:
IV: 1 mEq/kg/dose
Pediatric:
IV: 1 mEq/kg/dose
administration
IV: For direct IV infusion in emergencies, administer slowly
onset
Rapid
duration
8 to 10 minutes
notes
- Reactions with other drugs: Inactivates catecholamines and causes calcium to precipitate. Flush IV tubing before and after administration.
- Ventilation: Adequate alveolar ventilation is the mainstay in the control of acid base balance in cardiac arrest.
- Volume overload: Monitor patient closely for development of fluid overload (rales, peripheral edema, pink frothy sputum)
dosage form
IV Solution: 8.4% (10 mL, 50 mL)
adverse reactions
- Cardiovascular
- Heart failure
- Edema
- Dermatologic
- Extravasation can cause tissue necrosis
- Endocrine & metabolic
- Hypernatremia
- Hypocalcemia
- Hypokalemia
- Metabolic alkalosis
- Respiratory
- Pulmonary edema
structure